Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (11)

2021

  1. Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)

    ESMO Open, Vol. 6, Núm. 2

  2. Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)

    ESMO open, Vol. 6, Núm. 4, pp. 100215

  3. Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept

    Clinical and Translational Oncology, Vol. 23, Núm. 8, pp. 1520-1528

2020

  1. Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)

    European Journal of Cancer Care, Vol. 29, Núm. 4

2019

  1. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 55-63

  2. The Medical Oncology resident mentor: situation and workload

    Clinical and Translational Oncology, Vol. 21, Núm. 3, pp. 304-313

2016

  1. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)

    Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1172-1178

2014

  1. Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Clinical and Translational Oncology, Vol. 16, Núm. 3, pp. 243-256

2013

  1. Recomendaciones para la Determinación de Biomarcadores en Tumores Endocrinos Gastroenteropancreáticos. Consenso nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica

    Revista Espanola de Patologia

2010

  1. SEOM clinical guidelines for the adjuvant treatment of colorectal cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 724-728

2009

  1. Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study

    Critical Reviews in Oncology/Hematology, Vol. 70, Núm. 2, pp. 134-144